951 related articles for article (PubMed ID: 19892975)
1. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.
Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Veres G; Schmidt M; Kutschera I; Vidaud M; Abel U; Dal-Cortivo L; Caccavelli L; Mahlaoui N; Kiermer V; Mittelstaedt D; Bellesme C; Lahlou N; Lefrère F; Blanche S; Audit M; Payen E; Leboulch P; l'Homme B; Bougnères P; Von Kalle C; Fischer A; Cavazzana-Calvo M; Aubourg P
Science; 2009 Nov; 326(5954):818-23. PubMed ID: 19892975
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.
Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Bougnères P; Schmidt M; Kalle CV; Fischer A; Cavazzana-Calvo M; Aubourg P
Methods Enzymol; 2012; 507():187-98. PubMed ID: 22365775
[TBL] [Abstract][Full Text] [Related]
3. [Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector].
Cartier N; Hacein-Bey-Abina S; Von Kalle C; Bougnères P; Fischer A; Cavazzana-Calvo M; Aubourg P
Bull Acad Natl Med; 2010 Feb; 194(2):255-64; discussion 264-8. PubMed ID: 21166117
[TBL] [Abstract][Full Text] [Related]
4. Medicine. A comeback for gene therapy.
Naldini L
Science; 2009 Nov; 326(5954):805-6. PubMed ID: 19892968
[No Abstract] [Full Text] [Related]
5. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
Eichler F; Duncan C; Musolino PL; Orchard PJ; De Oliveira S; Thrasher AJ; Armant M; Dansereau C; Lund TC; Miller WP; Raymond GV; Sankar R; Shah AJ; Sevin C; Gaspar HB; Gissen P; Amartino H; Bratkovic D; Smith NJC; Paker AM; Shamir E; O'Meara T; Davidson D; Aubourg P; Williams DA
N Engl J Med; 2017 Oct; 377(17):1630-1638. PubMed ID: 28976817
[TBL] [Abstract][Full Text] [Related]
6. Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice.
Benhamida S; Pflumio F; Dubart-Kupperschmitt A; Zhao-Emonet JC; Cavazzana-Calvo M; Rocchiccioli F; Fichelson S; Aubourg P; Charneau P; Cartier N
Mol Ther; 2003 Mar; 7(3):317-24. PubMed ID: 12668127
[TBL] [Abstract][Full Text] [Related]
7. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy.
Gong Y; Mu D; Prabhakar S; Moser A; Musolino P; Ren J; Breakefield XO; Maguire CA; Eichler FS
Mol Ther; 2015 May; 23(5):824-834. PubMed ID: 25592337
[TBL] [Abstract][Full Text] [Related]
8. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
Weber FD; Wiesinger C; Forss-Petter S; Regelsberger G; Einwich A; Weber WH; Köhler W; Stockinger H; Berger J
Hum Mol Genet; 2014 May; 23(10):2542-50. PubMed ID: 24363066
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy.
Gupta AO; Raymond G; Pierpont EI; Kemp S; McIvor RS; Rayannavar A; Miller B; Lund TC; Orchard PJ
Expert Opin Biol Ther; 2022 Sep; 22(9):1151-1162. PubMed ID: 36107226
[TBL] [Abstract][Full Text] [Related]
10. Clinical, biochemical, neuroimaging and molecular findings of X-linked Adrenoleukodystrophy patients in South China.
Jiang MY; Cai YN; Liang CL; Peng MZ; Sheng HY; Fan LP; Lin RZ; Jiang H; Huang Y; Liu L
Metab Brain Dis; 2015 Dec; 30(6):1439-44. PubMed ID: 26260157
[TBL] [Abstract][Full Text] [Related]
11. The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy.
Ciftciler R; Goker H; Buyukasık Y; Topcu M; Gevher N; Demiroglu H
Transfus Apher Sci; 2020 Feb; 59(1):102583. PubMed ID: 31350055
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy.
Cartier N; Aubourg P
Brain Pathol; 2010 Jul; 20(4):857-62. PubMed ID: 20626747
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-Up of Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
Bougnères P; Hacein-Bey-Abina S; Labik I; Adamsbaum C; Castaignède C; Bellesme C; Schmidt M
Hum Gene Ther; 2021 Oct; 32(19-20):1260-1269. PubMed ID: 33789438
[TBL] [Abstract][Full Text] [Related]
14. Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy.
Orchard PJ; Nascene DR; Miller WP; Gupta A; Kenney-Jung D; Lund TC
Blood; 2019 Mar; 133(12):1378-1381. PubMed ID: 30635285
[TBL] [Abstract][Full Text] [Related]
15. Retroviral transfer and long-term expression of the adrenoleukodystrophy gene in human CD34+ cells.
Doerflinger N; Miclea JM; Lopez J; Chomienne C; Bougnères P; Aubourg P; Cartier N
Hum Gene Ther; 1998 May; 9(7):1025-36. PubMed ID: 9607414
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
Unterrainer G; Molzer B; Forss-Petter S; Berger J
Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
[TBL] [Abstract][Full Text] [Related]
17. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy strategies for X-linked adrenoleukodystrophy.
Cartier N
Curr Opin Mol Ther; 2001 Aug; 3(4):357-61. PubMed ID: 11525559
[TBL] [Abstract][Full Text] [Related]
19. In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment.
Hong SA; Seo JH; Wi S; Jung ES; Yu J; Hwang GH; Yu JH; Baek A; Park S; Bae S; Cho SR
Mol Ther; 2022 Jan; 30(1):119-129. PubMed ID: 34058389
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of X-linked adrenoleukodystrophy.
Berger J; Forss-Petter S; Eichler FS
Biochimie; 2014 Mar; 98(100):135-42. PubMed ID: 24316281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
